New MRI method could spot gut blood flow problems without radiation
NCT ID NCT07182669
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new, non-invasive MRI method to measure oxygen levels in the portal vein, which carries blood from the gut to the liver. Researchers will compare 20 people with meal-related abdominal pain due to narrowed gut arteries (chronic mesenteric ischemia) to 20 people with similar narrowing but no pain. The goal is to see if this MRI can accurately diagnose the condition without radiation or invasive procedures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this MRI method could provide a safe, radiation-free way to diagnose chronic mesenteric ischemia, reducing the need for invasive tests.
- What could go wrong
- This is a small, early-stage study with only 40 participants. The MRI method may not prove accurate enough for routine diagnosis, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients recruited from the participating hospital (Copenhagen University Hospital, Rigshospitalet and Copenhagen University Hospital, Hvidovre Hospital)
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \- Written informed consent * Male or female persons \> 18 years * Subjects with postprandial abdominal pain considered compatible with mesenteric ischemia, and severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound * OR subjects with severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound, but not postprandial pain Exclusion Criteria: * \- Serious concurrent illness * BMI \> 30 * Cardiac arrhythmia * Anemia with Hgb \< 7,0 mmol/l * Pregnancy or breastfeeding (urine HCG is performed on all fertile women) * Systolic blood pressure \< 90 or \> 200 mmHg * Claustrophobia * Patients who, in the judgement of the investigator, is incapable of participating * Metallic foreign objects in the body, or pacemakers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic mesenteric ischemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dept. of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet
Copenhagen, State, 2100 Ø, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.